1LAVIE P,HERRER P,HOFFSTEIN V.Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study[J].BMJ,2000,320(7233):479-482.
2SILVERBERG D S,OKSENBERG A.Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?[J].Curr Hypertens Rep,2001,3(3):209-215.
3GAMBINI G,ROSSI S,VALORI C.Absence of effects of Ketanserin on renal prostacyclin and thromboxane A2 in essential hypertension[J].Eur Heart J,1991,12(4):550-553.
4LAVIE L.Obstructive sleep apnoea syndrome an oxidative stress disorder[J].Sleep Med Rev,2003,7(1):35-51.
5KIMURA H,NIIJIMA M,ABE Y,et al.Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome[J].Intern Med,1998,37(2):127-133.
6BOULANGER C M.Secondary endothelial dysfunction: hypertension and heart-failure[J].J Mol Cell Cardiol,1999,31(1):39-49.
7DEAM R T,WILCOX I.Possible atherogenic effects of hypoxia during obstructive sleep apnea[J].Sleep,1993,16(8):15-21.